share_log

Piper Sandler Initiates Coverage On Cue Biopharma With Overweight Rating, Announces Price Target of $7

Piper Sandler Initiates Coverage On Cue Biopharma With Overweight Rating, Announces Price Target of $7

Piper Sandler以增持评级启动对Cue Biophma的报道,宣布目标价为7美元
Benzinga Real-time News ·  2022/11/21 05:08

Piper Sandler analyst Edward Tenthoff initiates coverage on Cue Biopharma (NASDAQ:CUE) with a Overweight rating and announces Price Target of $7.

Piper Sandler分析师Edward Tenthoff在Cue Biophma(纳斯达克:CUE)上以增持评级发起报道,并宣布目标价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发